Mo1228 DUPILUMAB NORMALIZES THE EOSINOPHILIC ESOPHAGITIS DISEASE TRANSCRIPTOME IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
Jennifer D. Hamilton(Regeneron (United States)), Allen Radin(Regeneron (United States)), Evan S. Dellon(University of North Carolina at Chapel Hill), Ikuo Hirano(Northwestern University), Sara Hamon, Margaret H. Collins(Cincinnati Children's Hospital Medical Center), Sivan Harel, Leda Mannent(Sanofi (France)), Neil M.H. Graham(UK Dementia Research Institute), Wei Keat Lim(Northwestern University), Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Mirna Chehade(Icahn School of Medicine at Mount Sinai), William R. Brian, Naimish Patel(Sanofi (United States)), Marcella Ruddy(Regeneron (United States)), Matthew F. Wipperman(Regeneron (United States))
Cited by 7
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k